Several anticancer agents including etoposide, paclitaxel, carboplatin, and melphalan have been shown to increase HSP expression, especially on the surface of exosome in hepatocarcinoma or multiple myeloma cells [17,18]. Here, HSP90B2P is linked to plasma cell myeloma.